5
Participants
Start Date
December 31, 2005
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
DTaP-Hep B-IPV Vaccine
U.S. licensed 13-Dec-2002. Dosage equal to 0.5 mL administered intramuscularly. Combination vaccine.
Monovalent Hep B Vaccine
U.S. licensed monovalent hepatitis B vaccine; each 0.5 mL dose contains 10 mcg of hepatitis B surface antigen absorbed on 0.25 mg aluminum hydroxide. The vaccine is given to infants as a 0.5 mL dose intramuscularly.
Placebo
Commercially prepared normal saline. The dose will be 0.5 mL administered intramuscularly.
UCLA Center For Vaccine Research, Torrance
National Institute of Allergy and Infectious Diseases (NIAID)
NIH